New Men B immunisation advice

Following recent high profile stories about child deaths from meningitis B, Public Health England has issued further advice:

Men B immunisation programme

Following recent media coverage about the death of a young girl from invasive meningococcal disease caused by Men B, many GP practices have had queries from parents about the availability of Men B immunisation. 

This information is taken from Public Health England publications and the GOV.UK website (see below for details).

What is the national policy for Men B immunisation?

The Men B immunisation programme started on 1 September 2015 for babies aged 2 months, ie, babies born on or after 1 July 2015.  There was a limited catch-up programme for babies born on or after 1 May 2015.  The routine schedule is for immunisation to be given at 2 and 4 months with the primaries, with a booster at 12 months.

Can I vaccinate children born before 1 May 2015 if parents request it? 

No. The national stock of Bexsero® should only be used to vaccinate children who are eligible for NHS vaccination.

Can I vaccinate children born on or after 1 May 2015 who have not yet been vaccinated?

Yes.  All children in the eligible cohort (ie, born on or after 1 May 2015) remain eligible for Men B immunisation until the age of two years. When Bexsero® has not been given as part of a primary course, give two doses at least two months apart. Those children who have received one dose before their first birthday only require one more dose. Please see the MenB PGD for more information.

If parents ask to pay for Men B immunisation for their children, what should I tell them?

GPs should not charge their own patients (ie, those registered at their practice) a private fee for the vaccine.

Parents seeking the vaccine privately should be made aware that they will be liable for the full costs of the vaccine and any additional administration charges that the private provider may apply. We understand that GSK has supply constraints on the Bexsero vaccine for the private market. Practices must not use centrally-procured stock for the national programme to vaccinate private patients or any patients outside the eligible cohort (other than those at high risk as defined in the green book).

Further information

Last updated : 16 Mar 2016

 

New guide to the Covid Vaccination Enhanced Service (ES) (25 Nov 2020)

New guidance for London practices and PCNs on the Covid Vaccination Enhanced Service (ES) is now available on our new purpose-built microsite. As new information is made available we will...
Read more »

Latest LMC workforce survey - please complete our short survey by Wednesday 9 December 2020 (24 Nov 2020)

Thank you in advance for making space in your busy day to complete our short survey on practice workforce issues. This will help us gather insight to share with key...
Read more »

Living Guide and Flu Guide updates November 2020 (24 Nov 2020)

Since mid-October when we sent out our last newsletter, our Living Guide has been updated a number of times which includes added information on long-term conditions. The following accompanying...
Read more »

Connecting sessional GPs and practices (24 Nov 2020)

During these difficult times we appreciate that a number of our sessional GPs working in London have found it difficult to find sessions, yet general practice is under extreme workload...
Read more »

Motions for Conference of England LMCs 2020 (20 Nov 2020)

The England Conference of LMCs will take place on Friday 27 November and is being held virtually for the first time. The full agenda is available to view here, motions...
Read more »

NHSmail for all GP roles (21 Oct 2020)

All GPs are eligible for an NHS email (‘NHSmail’) account, regardless of whether you are a partner, locum or salaried, and it has never been easier to get registered.   NHSmail accounts have...
Read more »
Next Page »
« Previous Page